Discover
IPSC
Century Therapeutics, Inc.
2.39
2 x 1.80
2 x 2.94
bid
ask
-
0.06
2.45%
2 @ 04:02 AM
2.41 +0.02 (0.84%)
| Ytd | 140.20% | |
| 1y | 340.15% |
2.29
day range
2.50
0.43
52 week range
3.04
| Open | 2.42 | Prev Close | 2.45 | Low | 2.29 | High | 2.50 | Mkt Cap | 431.05M |
| Vol | 2.02M | Avg Vol | 1.29M | EPS | -1.14 | P/E | N/A | Forward P/E | -0.76 |
| Beta | 1.42 | Short Ratio | 4.82 | Inst. Own | 61.11% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 2.28 | 200-d Avg | 1.59 | 1yr Est | 9.67 |
IPSC News
benzinga.com
Concentrix Reports Downbeat Q2 Earnings, Joins Nuvectis Pharma, Vishay Intertechnology And Other Big
US stock futures up, Dow futures gain 100+ points. Concentrix Corp (CNXC) shares down 24% after weak
benzinga.com
Apogee Enterprises Posts Strong Q1 Earnings, Joins ACADIA Pharmaceuticals, Crocs And Other Big Stock
Apogee Enterprises Inc (NASDAQ: APOG) rose sharply after the company reported better-than-expected f
benzinga.com
Century Therapeutics Announces Presentation Of New Preclinical Data At American Diabetes Association
CNTY-813 is Century's potential iPSC-derived islet replacement therapy for T1D. CNTY-813 is engi
benzinga.com
Graham, Appian And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures rise, Nasdaq up 1%. Graham Corp shares down 8.7%. Other stocks declining in pre-m